These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 12441079)
1. Repeated cycles of alternate administration of fludarabine and Zidovudine plus Didanosine inhibits murine AIDS and reduces proviral DNA content in lymph nodes to undetectable levels. Fraternale A; Casabianca A; Orlandi C; Chiarantini L; Brandi G; Silvestri G; Magnani M Virology; 2002 Oct; 302(2):354-62. PubMed ID: 12441079 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of murine AIDS by alternate administration of azidothymidine and fludarabine monophosphate. Fraternale A; Casabianca A; Tonelli A; Vallanti G; Chiarantini L; Brandi G; Celeste AG; Magnani M J Acquir Immune Defic Syndr; 2000 Mar; 23(3):209-20. PubMed ID: 10839656 [TBL] [Abstract][Full Text] [Related]
3. New treatment protocol including lympholytic and antiretroviral drugs to inhibit murine AIDS. Fraternale A; Tonelli A; Casabianca A; Chiarantini L; Schiavano GF; Celeste AG; Magnani M J Acquir Immune Defic Syndr; 2000 Feb; 23(2):107-13. PubMed ID: 10737424 [TBL] [Abstract][Full Text] [Related]
4. Macrophage protection by addition of glutathione (GSH)-loaded erythrocytes to AZT and DDI in a murine AIDS model. Fraternale A; Casabianca A; Orlandi C; Cerasi A; Chiarantini L; Brandi G; Magnani M Antiviral Res; 2002 Dec; 56(3):263-72. PubMed ID: 12406509 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of murine AIDS by combination of AZT and dideoxycytidine 5'-triphosphate. Fraternale A; Casabianca A; Rossi L; Chiarantini L; Brandi G; Aluigi G; Schiavano GF; Magnani M J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jun; 12(2):164-73. PubMed ID: 8680888 [TBL] [Abstract][Full Text] [Related]
6. Competitive PCR for quantification of BM5d proviral DNA in mice with AIDS. Casabianca A; Vallanti G; Magnani M J Clin Microbiol; 1998 Aug; 36(8):2371-4. PubMed ID: 9666028 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of murine AIDS by a new azidothymidine homodinucleotide. Magnani M; Casabianca A; Fraternale A; Brandi G; Chiarantini L; Benatti U; Scarfì S; Millo E; De Flora A J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Mar; 17(3):189-95. PubMed ID: 9495216 [TBL] [Abstract][Full Text] [Related]
8. Role of macrophage protection in the development of murine AIDS. Fraternale A; Tonelli A; Casabianca A; Vallanti G; Chiarantini L; Schiavano GF; Benatti U; De Flora A; Magnani M J Acquir Immune Defic Syndr; 1999 Jun; 21(2):81-9. PubMed ID: 10360798 [TBL] [Abstract][Full Text] [Related]
9. Combination of inhibitors of lymphocyte activation (hydroxyurea, trimidox, and didox) and reverse transcriptase (didanosine) suppresses development of murine retrovirus-induced lymphoproliferative disease. Mayhew CN; Sumpter R; Inayat M; Cibull M; Phillips JD; Elford HL; Gallicchio VS Antiviral Res; 2005 Jan; 65(1):13-22. PubMed ID: 15652967 [TBL] [Abstract][Full Text] [Related]
10. Cellular proviral HIV type 1 DNA load persists after long-term RT-inhibitor therapy in HIV type 1 infected persons. Bruisten SM; Reiss P; Loeliger AE; van Swieten P; Schuurman R; Boucher CA; Weverling GJ; Huisman JG AIDS Res Hum Retroviruses; 1998 Aug; 14(12):1053-8. PubMed ID: 9718120 [TBL] [Abstract][Full Text] [Related]
11. Human immunodeficiency virus proviral DNA from peripheral blood and lymph nodes demonstrates concordant resistance mutations to zidovudine (codon 215) and didanosine (codon 74). Division of AIDS Treatment Research Initiative 003 Study Group. Mayers D; Bethel J; Wainberg MA; Weislow O; Schnittman S J Infect Dis; 1998 Jun; 177(6):1730-3. PubMed ID: 9607859 [TBL] [Abstract][Full Text] [Related]
12. Antiretroviral effect of combined zidovudine and reduced glutathione therapy in murine AIDS. Magnani M; Fraternale A; Casabianca A; Schiavano GF; Chiarantini L; Palamara AT; Ciriolo MR; Rotilio G; Garaci E AIDS Res Hum Retroviruses; 1997 Sep; 13(13):1093-9. PubMed ID: 9282814 [TBL] [Abstract][Full Text] [Related]
13. Zidovudine therapy and HIV type 1 mutations in children with symptomatic HIV type 1 infection: effect of switching to didanosine or zidovudine plus didanosine therapy. Italian Multicenter Study Group on HIV Mutations in Children. Principi N; Marchisio P; Esposito S; Rossi P; Gattinara GC; Galli L; Gabiano C; Zuccotti GV; Orlandi P AIDS Res Hum Retroviruses; 1998 Dec; 14(18):1653-9. PubMed ID: 9870319 [TBL] [Abstract][Full Text] [Related]
14. Effect of macrophage depletion on viral DNA rebound following antiretroviral therapy in a murine model of AIDS (MAIDS). Serafini S; Fraternale A; Rossi L; Casabianca A; Antonelli A; Paoletti MF; Orlandi C; Pierigè F; Sfara C; Schiavano GF; Magnani M Antiviral Res; 2009 Feb; 81(2):93-102. PubMed ID: 18977391 [TBL] [Abstract][Full Text] [Related]
15. Virus burden in lymph nodes and blood of subjects with primary human immunodeficiency virus type 1 infection on bitherapy. Perrin L; Yerly S; Marchal F; Schockmel GA; Hirschel B; Fox CH; Pantaleo G J Infect Dis; 1998 Jun; 177(6):1497-501. PubMed ID: 9607825 [TBL] [Abstract][Full Text] [Related]
16. New drug combinations for the treatment of murine AIDS and macrophage protection. Fraternale A; Casabianca A; Tonelli A; Chiarantini L; Brandi G; Magnani M Eur J Clin Invest; 2001 Mar; 31(3):248-52. PubMed ID: 11264653 [TBL] [Abstract][Full Text] [Related]
17. Results of the ALBI trial: a randomized comparison of stavudine/didanosine, zidovudine/lamivudine and alternating treatment in antiretroviral-naive patients. Molina JM; Chêuc G; Ferchal F; Journot V; Pellegrin I; Sombardier MN; Rancinan C; Cotte L; Madelaine I; Debord T; Decazes JM; Antivir Ther; 1999; 4 Suppl 3():71-4. PubMed ID: 16021874 [TBL] [Abstract][Full Text] [Related]
18. Dissociation between lymphoproliferative responses and virus replication in mice with different sensitivities to retrovirus-induced immunodeficiency. Pozsgay JM; Reid S; Pitha PM J Virol; 1993 Feb; 67(2):980-8. PubMed ID: 8380473 [TBL] [Abstract][Full Text] [Related]
19. Effect of cyclophosphamide, total body irradiation, and zidovudine on retrovirus proliferation and disease progression in murine AIDS. Klinman DM; Krieg A; Conover J; Ussery MA; Black PL AIDS Res Hum Retroviruses; 1992 Jan; 8(1):101-6. PubMed ID: 1310603 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of murine AIDS by a heterodinucleotide of azidothymidine and 9-(R)-2-(phosphonomethoxypropyl)adenine. Rossi L; Serafini S; Franchetti P; Casabianca A; Orlandi C; Schiavano GF; Carnevali A; Magnani M J Antimicrob Chemother; 2002 Nov; 50(5):639-47. PubMed ID: 12407119 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]